---
category: news
title: "Novartis, Sarepta join Dyno’s enterprise to boldly go to new gene therapy frontier"
excerpt: "Dyno Therapeutics Inc., an early stage gene therapy firm applying artificial intelligence to advanced capsid engineering, has entered partnerships with Novartis AG and Sarepta Therapeutics Inc., in ophthalmic indications and muscle diseases,"
publishedDateTime: 2020-05-11T23:09:00Z
webUrl: "https://www.bioworld.com/articles/434990-novartis-sarepta-join-dynos-enterprise-to-boldly-go-to-new-gene-therapy-frontier"
type: article
quality: 33
heat: 33
published: false

provider:
  name: BioWorld
  domain: bioworld.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.bioworld.com/ext/resources/Stock-images/Deals-and-MAs/Deal-partnership-chain-link.png?height=635&t=1588276656&width=1200"
    width: 847
    height: 635
    isCached: true
    title: "Novartis, Sarepta join Dyno’s enterprise to boldly go to new gene therapy frontier"

secured: "lT6b+Tasg2Xz3T9xF4knkQscfgB6hRRfiX0/61MmJmUDEbiYKP+ZIRUDa6/hut6CABezYYyeWfUlt2SdfkTyiev1W88mrCc3Su3WjZHFBaLRBya+DS6Rj3RZz5TU0oi7K/hX1/a70RyE64ayFFKRtdjZmXyVPFTbj6Zg6CujUNaC7HRb4ioGlsOrlNw8f8V27AIAgcequWqfJedXi8OQY+enPxd5lXC5efE5qFrCqFKWrbLne0iH/X+07zfQcvI/kq61rfjysJwQE/mnaiMznEpaWHpxGAB+Uu5RTMEcK9WmZm18TquggTQ2BiO3Nnku7PjB5caABvcf0DsxpmUncUhRbf+D/LAldNzB2FmFVgeLQJBlvIwNLKWxP2E87T2dIwVGRiatCoTg5GzSgcM9bAe+z71DDZxy8xlpR/SdXkOi37Obxf3epdsmN2yve9D/xF9lMxNu4KCOarIQGIPgCGf2G9iCL6Nmmh0s4QLJXho=;lujTPUBpeWGJt/QvQLlhlw=="
---

